4.3 Article

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity

Journal

ONCOTARGET
Volume 7, Issue 11, Pages 13093-13105

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.7597

Keywords

influenza; NK; 2B4; NTB-A; NKp46

Funding

  1. European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant [320473-BacNK]
  2. I-CORE Program of the Planning and Budgeting Committee
  3. Israel Science Foundation
  4. I-Core on Chromatin and RNA in Gene Regulation
  5. GIF foundation
  6. Lewis family foundation
  7. ICRF professorship grant
  8. Israeli Science Foundation
  9. Helmholtz Israel grant
  10. Rosetrees Trust
  11. ISF grant [472/15]
  12. Rosetrees Trust [M416, M21-F1] Funding Source: researchfish

Ask authors/readers for more resources

Natural Killer (NK) cells are critical in the defense against viruses in general and against influenza in particular. We previously demonstrated that the activating NK cell receptor NKp46 is involved in the killing of influenza-virus infected cells through its interaction with viral hemagglutinin (HA). Furthermore, the recognition by NKp46 and consequent elimination of influenza infected cells were determined to be sialic-acid dependent. Here, we show that the human co-activating receptors 2B4 and NTB-A directly recognize the viral HA protein and co-stimulate killing by NK cells. We demonstrate that the 2B4/NTB-A-HA interactions require the sialylation of these receptors, and we identified the binding sites mediating these interactions. We also show that the virus counters these interactions through its neuraminidase (NA) protein. These results emphasize the critical role played by NK cells in eliminating influenza, a significant cause of worldwide morbidity and mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Anti-RhD antibody therapy modulates human natural killer cell function

Shlomo Elias, Inbal Kol, Shira Kahlon, Rajaa Amore, Mariam Zeibak, Dror Mevorach, Uriel Elchalal, Orly Zelig, Ofer Mandelboim

Summary: Anti-RhD antibodies are used to prevent RhD immunization, potentially by inducing NK cell degranulation. The mechanism involves CD16 activation and glycosylation of the antibodies. Additionally, the RhD drug may enhance killing of dendritic cells.

HAEMATOLOGICA (2021)

Article Virology

Altered NKp46 Recognition and Elimination of Influenza B Viruses

Alexandra Duev-Cohen, Batya Isaacson, Orit Berhani, Yoav Charpak-Amikam, Nehemya Friedman, Yaron Drori, Michal Mandelboim, Ofer Mandelboim

Summary: The study found that NKp46 can recognize influenza B viruses, but the interaction strength is weaker compared to influenza A, and NKp46 is not crucial for eliminating influenza B.

VIRUSES-BASEL (2021)

Review Immunology

Tumor resident regulatory T cells

Ariella Glasner, George Plitas

Summary: The immune system provides strong defense mechanisms against pathogens, but inadequate regulatory control can lead to various inflammatory disorders, including cancer. Treg cells play an important role in the tumor microenvironment, promoting tumor development by suppressing anti-tumor immune responses.

SEMINARS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain

Einat Seidel, Liat Dassa, Shira Kahlon, Boaz Tirosh, Anne Halenius, Tal Seidel Malkinson, Ofer Mandelboim

Summary: The study reveals that the glycoprotein US9 of human cytomegalovirus downregulates the activating immune ligand MICA*008 by slow cleavage of its signal peptide, leading to retention and degradation in the endoplasmic reticulum (ER) via the ER quality control system.

NATURE COMMUNICATIONS (2021)

Article Microbiology

The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing

Einat Seidel, Liat Dassa, Corinna Schuler, Esther Oiknine-Djian, Dana G. Wolf, Vu Thuy Khanh Le-Trilling, Ofer Mandelboim

Summary: The study reveals that the uncharacterized HCMV protein UL147A interferes with the immune response by downregulating the expression of the immune ligand MICA*008, hindering the elimination of HCMV-infected cells. This finding advances the understanding of complex HCMV immune evasion mechanisms and may facilitate the development of antiviral drugs and vaccines.

PLOS PATHOGENS (2021)

Article Immunology

The inhibitory receptor CD300a is essential for neutrophil-mediated clearance of urinary tract infection in mice

Batya Isaacson, Maya Baron, Rachel Yamin, Gilad Bachrach, Francesca Levi-Schaffer, Zvi Granot, Ofer Mandelboim

Summary: CD300a plays a crucial role in the neutrophil-mediated immune response to UPEC-induced urinary tract infection. Deficiency of CD300a impairs phagocytic abilities of neutrophils, leading to severe exacerbation of infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Review Dentistry, Oral Surgery & Medicine

Immune Changes Induced by Orthodontic Forces: A Critical Review

S. Chaushu, Y. Klein, O. Mandelboim, Y. Barenholz, O. Fleissig

Summary: The review critically summarizes the immune processes involved in orthodontic tooth movement (OTM) inflammation and provides insights into the relationship between classical inflammation and clinical OTM phases. Recent studies highlight the existence of a typical innate immune response in OTM, with partial resolution observed in the lag phase. Future studies are needed to further uncover cellular and molecular immune targets for developing strategies to control OTM through modulation of the inflammatory process.

JOURNAL OF DENTAL RESEARCH (2022)

Editorial Material Allergy

Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

Pier Giorgio Puzzovio, Ron Eliashar, Francesca Levi-Schaffer

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Immunology

The regulatory role of eosinophils in viral, bacterial, and fungal infections

Pratibha Gaur, Ilan Zaffran, Tresa George, Fidan Rahimli Alekberli, Micha Ben-Zimra, Francesca Levi-Schaffer

Summary: This review summarizes updated information on the direct and indirect interactions of eosinophils with pathogens. Eosinophils, traditionally associated with allergic and parasitic diseases, have been shown to play a role in maintaining homeostasis and fighting infectious diseases. They possess various cellular mechanisms to combat pathogens and contribute to an efficient immune response.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Review Allergy

Selected recent advances in understanding the role of human mast cells in health and disease

Francesca Levi-Schaffer, Bernhard F. Gibbs, Jenny Hallgren, Carlo Pucillo, Frank Redegeld, Frank Siebenhaar, Joana Vitte, Soraya Mezouar, Moiese Michel, Pier Giorgio Puzzovio, Marcus Maurer

Summary: With the advancement of research technologies and methodologies, there has been an increased understanding of the origin, development, function, and interactions of human mast cells. The potential contribution of mast cells to disease has led to the development of novel therapeutic approaches.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT

Yoav Charpak-Amikam, Tom Lapidus, Batya Isaacson, Alexandra Duev-Cohen, Tal Levinson, Adi Elbaz, Francesca Levi-Schaffer, Nir Osherov, Gilad Bachrach, Lois L. Hoyer, Maya Korem, Ronen Ben-Ami, Ofer Mandelboim

Summary: This study identifies how Candida albicans evades the immune response by manipulating the immune checkpoint receptor TIGIT. The results suggest that immunotherapy using a TIGIT-blocking antibody can restore anti-Candida immunity and serve as a potential therapeutic tool.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells

Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Jonjic Stipan, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer

Summary: We investigated the effect of activating CEACAM1 on melanoma cells and found that it induced apoptosis. In vivo experiments also showed a slight inhibitory effect on tumor weight.

CANCER GENE THERAPY (2022)

Correction Biotechnology & Applied Microbiology

Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (vol 29, pg 1676, 2022)

Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Stipan Jonjic, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer

CANCER GENE THERAPY (2023)

Review Allergy

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases

Martin Metz, Pavel Kolkhir, Sabine Altrichter, Frank Siebenhaar, Francesca Levi-Schaffer, Bradford A. Youngblood, Martin K. Church, Marcus Maurer

Summary: Chronic urticaria is a mast cell-dependent disease with limited therapeutic options. Current strategies focus on inhibiting IgE-mediated activation of mast cells and antagonizing the effects of released mediators. MC silencers have been developed as a new strategy to selectively block mast cell activation without causing immunosuppressive adverse effects.

ALLERGY (2023)

Article Immunology

2B4: A potential target in Staphylococcus aureus associated allergic inflammation

Pratibha Gaur, Mansour Seaf, Nirit Trabelsi, Orly Marcu, Daria Gafarov, Ora Schueler-Furman, Ofer Mandelboim, Micha Ben-Zimra, Francesca Levi-Schaffer

Summary: This study confirms that the staphylococcus aureus exotoxin SEB can bind and activate the 2B4 receptor, exacerbating inflammation. 2B4 plays a crucial role in SA-associated inflammation and may serve as an interesting therapeutic target.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)

No Data Available